Tecfidera - direct healthcare professional communication (DHPC)

dimethyl fumarate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Tecfidera (dimethyl fumarate): Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia

Key facts

• Medicine name:
  Tecfidera
• Active substance:
  dimethyl fumarate
• Therapeutic area (MeSH):
  Multiple Sclerosis
• Procedure number:
  EMEA/H/C/002601/II/0063
• Regulatory outcome:
  Variation
• DHPC type:
  Type II variation
• Human ATC codes:
  L04AX07
• Dissemination date:
  12/11/2020